ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?

  • 0Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

|

|

Summary

No abstract available on PubMed

Related Concept Videos